Metrikler
Yayın
24
Açık Erişim
7
BM Sürdürülebilir Kalkınma Amaçları
Araştırma Alanları
Sağlık Bilimleri
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Makaleler
Tümü (24)
SCI-E, SSCI, AHCI (23)
SCI-E, SSCI, AHCI, ESCI (23)
Scopus (24)
TRDizin (3)
2025
20251. Relationship Between Ultrasound and Physical Examination in the Assessment of Enthesitis in Patients With Spondyloarthritis: Results From the DEUS Multicenter Study
Di Matteo A., Di Donato S., Smerilli G., Becciolini A., Camarda F., Cauli A., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.77, ss.22-33, 2025 (SCI-Expanded, Scopus)
2024
20242. Addressing Glucocorticoid-Related Problems with the Clinical Pharmacist Collaboration in Rheumatology Practice: A Prospective Follow-Up Study
Bahap-Kara M., SARIYILDIZ E., YARDIMCI G. K., KARADAĞ Ö., EKİNCİOĞLU A.
RHEUMATOLOGY AND THERAPY
, cilt.11, sa.4, ss.1043-1055, 2024 (SCI-Expanded, Scopus)
2024
20243. Prospective assessment of glucocorticoid toxicity in rheumatology practice: a focus on the glucocorticoid toxicity index
Bahap-Kara M., SARIYILDIZ E., ZENGİN H. Y., KARADAĞ Ö., EKİNCİOĞLU A.
RHEUMATOLOGY
, sa.3, ss.1010-1018, 2024 (SCI-Expanded, Scopus)
2024
20244. Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group
Caminati M., Fassio A., Alberici F., Baldini C., Bello F., Cameli P., et al.
Allergy: European Journal of Allergy and Clinical Immunology
, cilt.79, sa.2, ss.516-519, 2024 (SCI-Expanded, Scopus)
2024
20245. Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates
Sandal Uzun G., Taghiyeva A., Çakır İ. Y., Moral K., YARDIMCI G. K., Bölek E. Ç., et al.
International Journal of Rheumatic Diseases
, cilt.27, sa.1, 2024 (SCI-Expanded, Scopus)
2024
20246. Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study
Di Matteo A., Smerilli G., Di Donato S., Liu A. R., Becciolini A., Camarda F., et al.
Annals of the Rheumatic Diseases
, 2024 (SCI-Expanded, Scopus)
2024
20247. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)
BİLGİN E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., Karabacak M., Sadioğlu Çağdaş Ö., et al.
Internal and Emergency Medicine
, 2024 (SCI-Expanded, Scopus)
2023
20238. The predictors of paradoxical reactions, especially psoriasis, to biologic therapy—findings from the TReasure database: a 5-year follow-up study
YAĞIZ B., Lermi N., COŞKUN B. N., DALKILIÇ H. E., KİRAZ S., Erden A., et al.
Rheumatology (United Kingdom)
, cilt.62, sa.12, ss.3962-3967, 2023 (SCI-Expanded, Scopus)
2023
20239. Comment on: Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis by Humby et al.
Duran E., Yildirim B. E. S., Karadağ Ö.
Clinical and experimental rheumatology
, cilt.41, 2023 (SCI-Expanded, Scopus)
2023
202310. Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry
Duran E., Ozturk Z. O., BİLGİN E., BÜYÜKAŞIK Y., DİZDAR Ö., Yardimci G. K., et al.
Rheumatology and Therapy
, cilt.10, sa.4, ss.969-981, 2023 (SCI-Expanded, Scopus)
2023
202311. Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.
Can Bostan Ö., Duran E., Tuncay G., Cihanbeylerden M., Karadag Ö., Damadoglu E., et al.
The Journal of asthma : official journal of the Association for the Care of Asthma
, cilt.60, sa.5, ss.931-937, 2023 (SCI-Expanded, Scopus)
2023
202312. Interchangeability and adverse events in originator-rituximab and its biosimilar (CT-P10) among rheumatic patients: a real-life experience
Bahap-Kara M., Duran E., Bayraktar-Ekincioglu A., KARADAĞ Ö.
Internal and Emergency Medicine
, cilt.18, sa.3, ss.791-799, 2023 (SCI-Expanded, Scopus)
2023
202313. Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia?
Duran E., Kilic L., Durhan G., Inkaya A. Ç., Guven G. S., Karakaya G., et al.
Annals of the rheumatic diseases
, cilt.82, sa.4, 2023 (SCI-Expanded, Scopus)
2023
202314. Comparison of lupus nephritis and non-lupus nephritides in patients with systemic lupus erythematosus
DURAN E., BİLGİN E., KALYONCU U., ERTENLİ A. İ., YILDIRIM T., ARICI M., et al.
Ulusal Romatoloji Dergisi
, cilt.15, sa.1, ss.18-24, 2023 (Scopus, TRDizin)
2022
202215. Reliability assessment of the definition of ultrasound enthesitis in SpA: results of a large, multicentre, international, web-based study
Di Matteo A., Cipolletta E., Castaniti G. M. D., Smerilli G., Airoldi C., Aydin S. Z., et al.
RHEUMATOLOGY
, cilt.61, ss.4863-4874, 2022 (SCI-Expanded, Scopus)
2022
202216. Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience
SARIYILDIZ E., YILDIRIM T., Taghiyeva A., Bilgin E., ARICI M., Saglam E. A., et al.
LUPUS
, cilt.31, ss.1147-1156, 2022 (SCI-Expanded, Scopus)
2022
202217. Comparison of cardiovascular, cancer and herpes zoster risk of tofacitinib versus etanercept: single-centre observational study
BİLGİN E., SARIYILDIZ E., ÜNALDI E., KALYONCU U., KİRAZ S., Ertenli I.
RHEUMATOLOGY
, cilt.61, sa.9, 2022 (SCI-Expanded, Scopus)
2022
202218. Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results
AYAN G., Farisogullari B., BİLGİN E., BÖLEK E. Ç., KubraYardimci G., DURAN E., et al.
CLINICAL RHEUMATOLOGY
, cilt.41, sa.5, ss.1439-1446, 2022 (SCI-Expanded, Scopus)
2022
202219. The clinical features and treatment of eosinophilic granulomatosis with polyangiitis (EGPA) in Turkey: one or two distinct diseases?
DURAN E., CAN BOSTAN Ö., BİLGİN E., KAYA S. B., BÖLEK E. Ç., ÖZER S., et al.
INTERNAL AND EMERGENCY MEDICINE
, cilt.17, sa.3, ss.743-751, 2022 (SCI-Expanded, Scopus)
2022
202220. Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.
Farisoğulları B., Yardımcı G. K., Sarı A., Bilgin E., Bölek E. Ç., Duran E., et al.
Clinical and experimental rheumatology
, cilt.40, sa.1, ss.112-119, 2022 (SCI-Expanded, Scopus)
2021
202121. Cryoglobulinemic vasculitis: having giant steps; but there are still unanswered questions
KARADAĞ Ö., DURAN E.
INTERNAL AND EMERGENCY MEDICINE
, cilt.16, sa.1, ss.33-35, 2021 (SCI-Expanded, Scopus)
2021
202122. Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience
BİLGİN E., Ceylan F., DURAN E., Farisogullari B., BÖLEK E. Ç., YARDIMCI G. K., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.51, sa.1, ss.297-308, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202123. The frequency of Achilles and plantar calcaneal spurs in gout patients
DURAN E., BİLGİN E., ERTENLİ A. İ., KALYONCU U.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.51, sa.4, ss.1841-1848, 2021 (SCI-Expanded, Scopus, TRDizin)
2015
201524. Frailty prevalence and related factors in the older adult-FrailTURK Project.
Eyigör S., KUTSAL F. Y., Duran E., Huner B., Paker N., Durmus B., et al.
Age (Dordrecht, Netherlands)
, cilt.37, sa.3, ss.9791, 2015 (SCI-Expanded, Scopus)